NCT00058227 2013-06-04Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaNational Cancer Institute (NCI)Phase 1 Completed37 enrolled